Enanta Pharmaceuticals
ENTA
#8713
Rank
S$0.29 B
Marketcap
S$10.29
Share price
-3.04%
Change (1 day)
-35.02%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -S$64.74 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$65.25 Million. In 2025 the company made an earning of -S$82.5 Million, an increase over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$64.74 Million-21.53%
2025 -S$82.5 Million-34.07%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$86.18 Million-407.13%
2019 S$28.05 M-78.63%
2018 S$0.13 B117.97%
2017 S$60.24 M-574.65%
2016 -S$12.7 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.8 Million-137.98%
2012 S$60.01 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.14 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.30 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$16.52 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.88 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA